Cervical facet joint injury induces persistent pain and central sensitization. Preventing the peripheral neuronal signals that initiate sensitization attenuates neuropathic pain. Yet, there is no clear relationship among facet joint afferent activity, development of central sensitization, and pain, which may be hindering effective treatments for this pain syndrome. This study investigates how afferent activity from the injured cervical facet joint affects induction of behavioral sensitivity and central sensitization. Intra-articular bupivacaine was administered to transiently suppress afferent activity immediately or 4 days after facet injury. Mechanical hyperalgesia was monitored after injury, and spinal neuronal hyperexcitability and spinal expression of proteins that promote neuronal excitability were measured on day 7. Facet injury with saline vehicle treatment induced significant mechanical hyperalgesia (P < .027), dorsal horn neuronal hyperexcitability (P < .026), upregulation of pERK1/2, pNR1, mGluR5, GLAST, and GFAP, and downregulation of GLT1 (P < .032). However, intra-articular bupivacaine immediately after injury significantly attenuated hyperalgesia (P < .0001), neuronal hyperexcitability (P < .004), and dysregulation of excitatory signaling proteins (P < .049). In contrast, intra-articular bupivacaine at day 4 had no effect on these outcomes. Silencing afferent activity during the development of neuronal hyperexcitability (4 hours, 8 hours, 1 day) attenuated hyperalgesia and neuronal hyperexcitability (P < .045) only for the treatment given 4 hours after injury. This study suggests that early afferent activity from the injured facet induces development of spinal sensitization via spinal excitatory glutamatergic signaling. Peripheral intervention blocking afferent activity is effective only over a short period of time early after injury and before spinal modifications develop, and is independent of modulating spinal glial activation. Ó
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Introduction
Chronic pain from neck trauma or spinal pathology is a common clinical problem, with a 12-month prevalence of 30% to 50% in the general population [23] . The cervical facet joints are at risk for injury during abnormal neck motions and have been implicated in up to 60% of chronic pain cases [3, 38, 41] . Current treatments for facet joint-mediated pain include intra-articular injection of analgesics or corticosteroids, medial nerve block, and radiofrequency neurotomy of the nerve innervating the joint [2, 31, 39, 42] . Although these treatments can provide relief in some patients, it is often only temporary. It remains unclear whether the effectiveness of local interventions for spinal joint pain depends on the timing of the treatment relative to the onset of trauma and/or pain or the development of central changes that mediate persistent pain.
Interrupting the neuronal signals that initiate central sensitization has been a focus of therapeutic approaches to pre-emptively reduce postoperative pain [7, 55, 59] and to alleviate neuropathic pain after nerve injury [49, 60] . For nerve injury, early intervention that blocks discharges from the injured fibers is more effective at reducing or preventing neuropathic pain than treatments initiated after central sensitization has already developed [1, 20, [49] [50] [51] 60] . Injury to the cervical facet joint and its capsule is primarily a ligamentous injury; but, because the facet capsule is innervated, there 
